KATHY BERNSTEIN: Open Payments
NPI 1144642091 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 66 payments from 20 companies in 2025. Trend: 2023 $1,016 · 2024 $1,707 · 2025 $1,519
Food & beverage: $1,432Education: $88
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 7 | $223 |
| Dexcom, Inc. | 8 | $197 |
| Xeris Pharmaceuticals, Inc. | 10 | $188 |
| Abbott Laboratories | 5 | $175 |
| Novo Nordisk Inc | 10 | $165 |
| Mannkind Corporation | 4 | $92 |
| Lilly USA, LLC | 3 | $79 |
| PFIZER INC. | 3 | $59 |
| Ascendis Pharma Endocrinology Inc | 3 | $57 |
| Amgen Inc. | 2 | $45 |
Products named: iLet Bionic Pancreas, Dexcom G6 Transmitter, GVOKE HYPOPEN, FREESTYLE LIBRE 3, Ozempic, AFREZZA, PREVNAR 20, Yorvipath.
Industry payments across LA — which companies pay providers there.
